Related by context. All words. (Click for frequent words.) 84 ng ml 76 ng dL 76 nmol L 73 mg dL 72 pg mL 72 g dL 72 nanograms per 72 pg ml 71 mmol L 70 mmol l 70 nmol liter 69 mg dl 69 mEq L 69 μmol L 69 μg L 68 g dl 68 pmol L 67 mIU L 67 eGFR 67 mU L 67 hydroxyvitamin D levels 67 #.#ng/ml 67 #ng/ml 66 nmol L. 66 mL/min/#.# m 2 66 μg dL 66 creatinine ratio 66 ng dl 65 HbA 1c 65 PSA nadir 65 serum creatinine 65 mg d 65 mL min 64 nanograms milliliter 64 P = .# 64 nmol 64 mmHg 64 highest tertile 63 mcg mL 63 creatinine clearance 63 kg/m2 63 serum uric acid 63 confidence interval CI 63 serum calcium 63 Hb A1C 63 nmol l 63 baseline HbA1c 63 serum testosterone 63 transferrin saturation 63 serum sodium 62 tHcy 62 mIU ml 62 μg 62 serum potassium 62 alanine aminotransferase 62 mm Hg systolic 62 ml kg 62 creatinine 62 % CI #.#-#.# [006] 62 mm Hg 62 serum concentrations 62 hydroxyvitamin D 62 μg ml 62 μg mL 62 -#.# mg dL [002] 62 serum TSH 62 IU mL 62 Cmax 62 umol L 62 alanine aminotransferase ALT 62 mU liter 62 CK MB 62 log# copies mL 62 microalbuminuria 61 mg kg 61 mcg dL 61 mmol L. 61 ug kg 61 % Confidence Interval 61 lowest tertile 61 aspartate aminotransferase 61 serum PSA 61 glomerular filtration rate 61 sUA 61 serum IGF 61 μg d 61 μg l 61 LVEF 61 CrCl 61 glycated hemoglobin 61 HbA1c 61 per deciliter mg 61 urinary albumin 61 specific antigen PSA 61 #mmHg [002] 61 intact parathyroid hormone 61 x ULN 61 PaO 2 60 #mmHg [001] 60 D dimer 60 troponin T 60 urine albumin 60 #mg/dL [001] 60 thyroglobulin 60 ug L 60 hypogonadal 60 p = .# [002] 60 serum creatinine levels 60 mIU mL 60 albuminuria 60 biochemical recurrence 60 μg liter 60 μg kg 60 serum phosphorus 60 cTnI 60 ≥ 60 mL sec 60 nonfasting triglyceride levels 60 albumin excretion 60 lactate dehydrogenase LDH 60 biochemical relapse 60 statistical significance p 60 neutrophil counts 60 Median survival 60 hemoglobin A1c HbA1c 60 hemoglobin Hb 60 % CI #.#-#.# [002] 60 pmol liter 59 CI = 59 glycated hemoglobin levels 59 mL/min/#.# m2 59 sd = 59 IU ml 59 advanced adenomas 59 Serum creatinine 59 serum cortisol 59 μg dl 59 p = #.# [002] 59 elevated creatinine 59 mmHg diastolic 59 mcg kg 59 #.#mg/dL 59 PSADT 59 thyroid stimulating hormone 59 serum vitamin D 59 leukocyte count 59 nonfatal MI 59 % CI #.#-#.# [003] 59 aspartate aminotransferase AST 59 microg 59 μg g 59 serum albumin 59 glycosylated hemoglobin HbA1c 59 hsCRP levels 59 SCr 59 euthyroid 59 hydroxy vitamin D 59 plasma glucose levels 59 cTnT 59 mL kg 59 tPSA 59 mmol liter 59 hours postdose 58 creatinine levels 58 antibody titer 58 preoperative PSA 58 plasma leptin 58 lumbar spine BMD 58 MADRS score 58 mmHg systolic 58 nanograms 58 recurrent VTE 58 copies ml 58 HbA1c levels 58 uM 58 log# 58 #OHD 58 alkaline phosphatase 58 Hb A1c 58 HbA 1c levels 58 aminotransferases 58 urinary N telopeptide 58 urinary albumin excretion 58 plasma uric acid 58 -#.# ± [002] 58 serum HBV DNA 58 baseline Hb 58 copies mL 58 mmol 58 hemoglobin concentration 58 mg kg Hematide 58 statin monotherapy 58 cholesterol LDL C 58 tertile 58 milliliter ng mL 58 #mg/dL [002] 58 serum urate 58 nonobese 58 CI -#.# 58 mCi 58 serum magnesium 58 pT3 58 HGPIN 58 isoprostane 58 erythrocyte sedimentation rate 58 thyroid stimulating hormone TSH 58 nM 58 mg kg dose 58 Hb levels 58 nanomoles per 58 confidence interval #.#-#.# 58 proteinuria 58 serum glucose 57 eosinophil count 57 MBq 57 #mg/dl 57 interquartile range 57 glycated hemoglobin HbA1c 57 hypokalemia 57 deciliter 57 ejection fractions 57 serum PTH 57 HbA1C 57 neutrophil count 57 TT genotype 57 serum bilirubin 57 % CI #.#-#.# [007] 57 gastric pH 57 mg/m2 dose 57 nondiabetic patients 57 n = 57 albumin creatinine ratio 57 mg dose 57 lispro 57 milliliter ng ml 57 ± 57 CDAI score 57 lactate dehydrogenase 57 hemoglobin concentrations 57 NT proBNP 57 #.#/#.# mmHg [001] 57 HOMA IR 57 apnea hypopnea index 57 creatine kinase 57 BLLs 57 iPTH 57 aminotransferase levels 57 hematocrit 57 #OHD levels 57 advanced adenoma 57 gm dl 57 cystatin C 57 AST ALT 57 micromoles 57 #.#/#.# mm Hg [003] 57 mU 57 anti HBs 57 mm Hg diastolic 57 mean baseline HbA1c 57 ml min 57 fasting triglyceride levels 57 peginterferon alfa 2a 57 elevated ALT 57 HbA 1C 57 % CI #.#-#.# [001] 57 transaminases 57 mg TID 57 glycosylated hemoglobin 56 systolic BP 56 lymphocyte count 56 ug dL 56 per milliliter 56 SGPT 56 serum ferritin 56 plasma folate 56 thyrotropin levels 56 Prostate specific antigen 56 mg 56 elevated CRP 56 serum ALT 56 plasma homocysteine 56 #mg/kg [002] 56 fasting blood glucose 56 systolic dysfunction 56 C reactive protein 56 baseline serum creatinine 56 N telopeptide 56 homocysteine concentrations 56 ug mL 56 cells uL 56 serum estradiol 56 plasma concentrations 56 MMSE score 56 placebo p 56 ug ml 56 leukopenia 56 EDSS score 56 endometrial thickness 56 hip BMD 56 nondiabetic 56 #.#mmol l [002] 56 ìg 56 cortisol concentrations 56 estimated GFR 56 p = 56 IGFBP 56 interleukin IL -6 56 Hb 56 anemia hemoglobin 56 serum urate levels 56 mmHg p = 56 ug dl 56 mL 56 SUVmax 56 binary restenosis 56 Hazard Ratio HR 56 min -1 56 hs CRP 56 % CI #.#-#.# [004] 56 lymph node metastasis 56 hsCRP 56 univariate analysis 56 IPSS 56 serum phosphate 56 CR nPR 56 A1C levels 56 ALT elevation 56 normal ULN 56 fasting glucose 56 posttreatment 56 median PFS 56 OGTT 56 elevated LDH 56 p = #.# [004] 56 pg g 56 serum prostate 56 #.#mmol L [002] 56 abacavir lamivudine 55 A1c levels 55 EpCAM expression 55 nondiabetics 55 #ppb [001] 55 5-FU/LV 55 QTcF 55 cGy 55 mg l 55 -#.# log# 55 intima media thickness 55 posttransplant 55 preoperatively 55 serum phosphate levels 55 ertapenem 55 CI #.#-#.# [001] 55 PCa 55 elevated serum creatinine 55 urinary cortisol 55 nonfatal myocardial infarction 55 osteopenic 55 cardiovascular mortality 55 HIV RNA 55 estimated glomerular filtration 55 μmol 55 Index CDAI score 55 fasting plasma glucose FPG 55 COHb 55 statistically significant p = 55 MMSE scores 55 confidence intervals CIs 55 CVD mortality 55 serum aminotransferase levels 55 oral glucose tolerance 55 serum retinol 55 subclinical hypothyroidism 55 log# reduction 55 serum CRP 55 kg m² 55 mmol kg 55 #mg/day [001] 55 dehydroepiandrosterone sulfate 55 tertiles 55 fasting insulin 55 sUA levels 55 cells/mm3 55 antihypertensive medications 55 HBeAg seroconversion 55 FEV1 55 rs# [002] 55 Fasting glucose 55 mcg ml 55 pCR 55 mg/m2 55 d dimer 55 procalcitonin 55 μM 55 severe neutropenia 55 serum HCV RNA 55 hemoglobin A1c 55 X ULN 55 achieved ACR# 55 reinfarction 55 thyrotropin 55 NPH insulin 55 mcg 55 mol L 55 serum lipid levels 55 virologic failure 55 serum potassium levels 55 normotensive 55 ± SD 55 pCi l 55 advanced neoplasia 55 Plasma concentrations 55 thyroxine 55 intramuscularly 55 virologic response 55 HCV RNA 55 -#.# ± [001] 55 elevated LDL cholesterol 55 irbesartan 55 plasma urate 55 residual platelet reactivity 55 CsA 55 definite stent thrombosis 55 CD4 + cell 54 serum LDL cholesterol 54 micrograms mcg 54 protein excretion 54 cardiac troponin T 54 ^ sup 54 colorectal adenoma 54 fasting glucose levels 54 micromolar 54 exhaled nitric oxide 54 Index CDAI 54 thromboembolic events 54 baseline FEV 54 elevated uric acid 54 severe renal impairment 54 plasma cortisol 54 BMI ≥ 54 urinary excretion 54 SHBG levels 54 plasma glucose 54 endogenous EPO 54 lopinavir r 54 impaired fasting glucose 54 Non inferiority 54 glomerular filtration 54 inhibin B 54 DAS# [002] 54 mg kg bw 54 femoral neck BMD 54 diastolic pressure 54 EBRT 54 fosamprenavir 54 bioavailable testosterone 54 HBsAg 54 certolizumab 54 fructosamine 54 diastolic blood pressures 54 fluticasone salmeterol 54 oxycodone CR 54 kg -1 54 NNT = 54 subclinical hyperthyroidism 54 aminotransferase ALT 54 LDL cholesterol levels 54 dexamethasone 54 ACTH 54 RBC folate 54 mg tid 54 MetS 54 serum testosterone levels 54 PREZISTA ritonavir 54 QTc 54 adjunctive placebo 54 peptide BNP 54 macroalbuminuria 54 concomitant medications 54 P ≤ 54 serum folate 54 evaluable subjects 54 rheumatoid factor 54 serum phosphorus levels 54 tirofiban 54 antibody titers 54 urate levels 54 Crohn Disease Activity 54 postop 54 mcg kg min 54 follicle stimulating hormone FSH 54 mineral density 54 glulisine 54 β blockers 54 oral allopurinol 54 plasma HCV RNA 54 rhEPO 54 p ≤ 54 #ppb [003] 54 multivariable adjusted 54 undetectable HBV DNA 54 serum triglyceride 54 serum phosphorous 54 baseline A1C 54 glucuronide 54 Psoriasis Area 54 neurodevelopmental impairment 54 GnRH agonist 54 serum IgE 54 #/#mmHg 54 tipranavir r 54 mcg BID 54 undetectable HCV RNA 54 hemoglobin A1c levels 54 undetectable viral 54 paricalcitol 54 fasting plasma glucose 54 tHcy concentrations 54 triglyceride concentrations 54 serum homocysteine 54 mcg dose 54 index BMI 54 millimoles per 54 platelet reactivity 54 mg QD 53 placebo p = 53 loop diuretics 53 mEq 53 IQR 53 ppb 53 lymphocyte counts 53 lopinavir r arm 53 8 OHdG 53 highest quintile 53 plasma selenium 53 mg m 53 adiponectin concentrations 53 tamsulosin 53 micrograms mL 53 AUC0 53 hemoglobin A1C 53 serum selenium 53 corticosteroid dose 53 serum calcium levels 53 insulin glargine 53 adenoma 53 moderate renal impairment 53 aged ≥ 53 fasting triglycerides 53 rs# [001] 53 undetectable viral load 53 infliximab monotherapy 53 cerebrovascular events 53 fractional shortening 53 TIMP 53 postoperative complication 53 NHANES III 53 mg mL 53 detectable HCV RNA 53 nanomolar 53 arterial oxygen saturation 53 prehypertensive 53 cTnT levels 53 IIIa inhibitors 53 mg/# hours 53 REYATAZ r arm 53 % CI #.#-#.# [008] 53 PASI scores 53 sensitivity specificity 53 aldosterone antagonist 53 pretest probability 53 hematuria 53 colorectal neoplasia 53 asymptomatic carotid stenosis 53 cells μL 53 dobutamine 53 thyroid hormone levels 53 salmeterol fluticasone propionate 53 total cholesterol LDL 53 vertebral fracture 53 coronary stenosis 53 androgen deprivation 53 AUCs 53 subtrochanteric 53 carotid IMT 53 #μg [001] 53 pCi 53 Calcium intake 53 eplerenone 53 rapid virological response 53 #mg doses [002] 53 left ventricular systolic 53 Kaplan Meier analysis 53 pCi L 53 #mg BID [003] 53 infarct size 53 multivariable analysis 53 HbA1C levels 53 nonfasting 53 unfractionated heparin 53 serum lactate 53 p = #.# [003] 53 serum triglycerides 53 Baseline characteristics 53 LAB GHRH 53 LV ejection fraction 53 elevated homocysteine 53 atorvastatin #mg 53 coronary revascularization 53 calculated creatinine clearance 53 CYP#A# [002] 53 URTI 53 BENICAR HCT 53 phthalate metabolites 53 μmol l 53 CK # plasma concentrations 53 chlorthalidone 53 follicle stimulating hormone 53 carotid stenosis 53 ALT elevations 53 primary aldosteronism 53 alteplase 53 NOAEL 53 mg qd 53 Ki# 53 fraction LVEF 53 elevated troponin 53 plasma renin activity 53 FOLFOX4 53 rs# [004] 53 Bq/m3 53 micrograms 53 NIHSS score 53 nonfasting triglycerides 53 = #.#-#.# 53 evaluable 53 mg BID 53 density lipoprotein cholesterol 53 microgram kg 53 #mm Hg 53 renal dysfunction 53 vitamin D2 53 lipoprotein levels 53 univariate analyzes 53 #ug [002] 53 statistically significant p 53 insulin detemir 53 urinary iodine 53 PREZISTA r arm 53 locoregional recurrence 53 adjunctive ABILIFY 53 milligrams 53 abciximab 53 systolic pressure 53 cfu 53 concentration Cmax 53 systemic embolism 53 serum sodium levels 53 hypophosphatemia 53 LS BMD 53 mM 53 A1c 53 p = NS 53 TIMP 1 53 milligrams deciliter 53 malondialdehyde 53 mCi m 2 53 plasma triglycerides 53 osmolality 53 underwent surgical resection 53 timepoint 53 mRNA expression 53 NATRECOR ® 53 hemoglobin levels 53 total cholesterol triglycerides 53 HI titers 53 mg/m2/day 53 CI #.#-#.# [002] 53 beta blocker therapy 53 urinary calcium 53 Inhibin B 53 radiotherapy RT 53 nicardipine 53 postoperative mortality 52 hyperoxia 52 Prostate Specific Antigen PSA 52 oxycodone IR 52 microalbumin 52 mg kg hr 52 clodronate 52 SGOT 52 Hazard Ratio 52 #mcg [003] 52 flutamide 52 nonpregnant women 52 comparator arm 52 intravesical therapy 52 PSA velocity 52 ABC/3TC 52 GSTM1 52 gm dL 52 antigen PSA 52 ppm U 52 mg Androxal 52 D Dimer 52 lumbar spine bone 52 steroid dexamethasone 52 alanine transaminase 52 NATRECOR R 52 hematologic toxicity 52 milligrams mg 52 nonsignificant 52 plasminogen activator inhibitor 52 ipsilateral stroke 52 #.#mmol L [001] 52 carcinoembryonic antigen 52 coinfected 52 methylmalonic acid 52 Myelosuppression 52 #ug [001] 52 dacarbazine 52 CC genotype 52 postoperative morbidity 52 GFR 52 lymph node metastases 52 seminal vesicle invasion 52 DLCO 52 myocardial infarction stroke 52 picograms 52 parasitaemia 52 MIC# [001] 52 ppm Cu 52 periprocedural 52 -#.# log# copies mL 52 creatine phosphokinase 52 UACR 52 AOR = 52 concentration BAC 52 tacrolimus 52 triglyceride 52 urine NGAL 52 NNRTI resistance 52 circulating IGF 52 mg kg -1 52 χ 52 hypopneas 52 adriamycin 52 serum sodium concentration 52 calcitriol 52 lymphocytosis 52 diastolic BP 52 oral antidiabetic medication 52 inotropic 52 glargine 52 renal function 52 noninferiority 52 XIENCE V PROMUS Stent 52 Hgb 52 hemodilution 52 KRAS mutations 52 mCi kg 52 HBeAg 52 histologically confirmed 52 Pred Forte 52 chlorambucil 52 prostate specific antigen 52 Triglyceride levels 52 â ‰ ¥ 52 HBV DNA levels 52 left ventricular hypertrophy 52 1c HbA 1c 52 sweat chloride 52 hemodynamically significant 52 systemic corticosteroid 52 plasma creatinine 52 mild renal impairment 52 ergocalciferol 52 pmol 52 placebo 52 hyperphenylalaninemia HPA due 52 LDL C 52 fetuin 52 test OGTT 52 microgram 52 darbepoetin alfa 52 hydroxyvitamin D concentrations 52 Ishak fibrosis score 52 serum thyroglobulin 52 glycemia 52 ß = 52 nonfatal stroke 52 Fasting plasma glucose 52 HER2 expression 52 μSv 52 glycoprotein IIb IIIa inhibitors 52 amprenavir 52 isoenzyme 52 polyp recurrence 52 urate 52 mg m² 52 mcg QD 52 creatine kinase MB 52 Homocysteine levels 52 nelfinavir 52 mm3 52 serum leptin 52 #mg/day [002] 52 onset diabetes mellitus 52 angiotensin converting enzyme 52 abdominal circumference 52 pulmonary artery pressure 52 YKL 52 cytopenias 52 plus medroxyprogesterone acetate 52 elevated transaminases 52 elevated blood glucose 52 HBV DNA 52 B7 H3 52 LEXIVA r 52 apolipoprotein B 52 oral prednisone 52 ALT normalization 52 HDL2 52 3mg 52 azacitidine 52 parous women 52 achieved PASI 52 gestational hypertension 52 diastolic hypertension 52 amoxicillin clavulanate 52 curve AUC 52 NGAL 52 normothermic 52 pbb 52 preserved ejection fraction 52 #mg BID [001] 52 progression TTP 52 IGFBP 3 52 HER2 amplification 52 LPV r 52 dose colchicine 52 liver histology 52 kcal d 52 epoetin alfa 52 NIHSS 52 mg RDEA# 51 HIV HCV coinfected 51 plasma renin 51 clinically insignificant 51 hemoglobin 51 Fasting blood glucose 51 folate intake 51 ritonavir boosted 51 hypotension 51 antigen PSA levels 51 Operative mortality 51 thyroxine T4 51 asthma exacerbation 51 complete cytogenetic response 51 HDRS 51 A1C 51 mrem 51 dapagliflozin plus 51 Prostate Specific Antigen 51 CIN2 + 51 inotropic agents 51 PCA3 scores 51 eptifibatide 51 rizatriptan 51 airway responsiveness 51 rs# [003] 51 mcg Albuferon 51 % CI #.#-#.# [005] 51 HES CEL 51 biopsy Gleason 51 T2DM 51 cardiovascular hospitalizations 51 stone formers 51 per deciliter 51 mg Lucentis 51 imatinib therapy 51 fluorouracil 51 intraobserver 51 CDAI 51 vitamin D intakes 51 vasopressor 51 HDL C 51 #ppb gold 51 enterolactone 51 mu g 51 timepoints 51 postoperatively 51 triacylglycerol concentrations 51 1ppm 51 #.#ml [002] 51 ketorolac 51 myeloperoxidase 51 urate lowering therapy 51 hormone receptor negative 51 receiving Vectibix monotherapy 51 seropositivity 51 distant metastasis 51 isoproterenol 51 hypercalcemia 51 aspartate 51 mucosal healing 51 diastolic blood pressure 51 Creatinine 51 NSTE ACS 51 glucocorticoid 51 MELD scores 51 Platelet counts 51 parathyroid hormone 51 FDG uptake 51 kidney dysfunction 51 kDa 51 fasting serum 51 PREZISTA r 51 folic acid supplement 51 orchiectomy 51 diuretic chlorthalidone 51 kidney allograft 51 hCG human chorionic 51 titers 51 lymph node involvement 51 doxorubicin docetaxel 51 posaconazole 51 severe exacerbations 51 troponin 51 distant metastases 51 #beta 51 ropivacaine 51 c reactive protein 51 mcg albinterferon alfa 2b 51 gestational age 51 colorectal neoplasms 51 estradiol 51 nonvertebral fractures 51 titrated 51 prostate cancer PCa 51 lymphadenectomy 51 ACR# response 51 pioglitazone 51 postintervention 51 fluvastatin 51 colorectal polyp 51 isolated systolic hypertension 51 picogram 51 laboratory abnormalities 51 -#.# mg dL [001] 51 Severe hypoglycemia 51 DAS# scores 51 hypogonadal men 51 NNAL 51 intramuscular dose 51 OADs 51 platelet inhibition 51 symptom onset 51 log# IU mL 51 IOP lowering 51 elevated TSH 51 Hcy 51 preintervention 51 cm H2O 51 Complication rates 51 hepatorenal syndrome 51 serum triglyceride levels 51 transdermal estradiol 51 TAXUS p value 51 β blocker 51 CCyR 51 transaminase elevations 51 EDSS scores 51 symptomatic intracranial hemorrhage 51 mg eq 51 human chorionic gonadotropin hCG 51 cefazolin 51 epithelial ovarian cancer 51 serum lipid 51 #.#mg [004] 51 NYHA class 51 triacylglycerol 51 HBeAg negative patients 51 TNF alpha IL 51 neoadjuvant chemotherapy 51 F FDG 51 Insulin sensitivity 51 nondepressed 51 iodixanol 51 baseline CD4 51 renal insufficiency 51 4mg/kg 51 incontinence episodes 51 prostate specific 51 GH secretion 51 noninferior 51 postprandial glucose 51 ATACAND 51 nonsignificant difference